Kim Flora S, Kelley Walter, Resh Brooke, Goldenberg Gary
University of Virginia School of Medicine, Charlottesville, VA, USA.
J Cutan Pathol. 2009 Jul;36(7):793-5. doi: 10.1111/j.1600-0560.2008.01103.x.
A 64-year-old Caucasian male was seen in consultation for a petechial eruption that began 9 days after he started linezolid therapy for a retroperitoneal abscess. Skin findings included confluent non-blanching petechiae and purpura covering his entire body, without any active bleeding. A punch biopsy from the left lateral arm was performed and showed a perivascular inflammatory infiltrate composed of lymphocytes, histiocytes and rare eosinophils, and extravasated erythrocytes. Changes of leukocytoclastic vasculitis were not noted. Linezolid was promptly discontinued. To our knowledge, this is the first report of a biopsy-proven purpuric medication reaction secondary to linezolid therapy.
一名64岁的白种男性因在开始使用利奈唑胺治疗腹膜后脓肿9天后出现瘀点疹前来会诊。皮肤检查发现全身布满融合性、不褪色的瘀点和紫癜,无任何活动性出血。对左侧手臂进行了打孔活检,结果显示血管周围有由淋巴细胞、组织细胞和罕见嗜酸性粒细胞组成的炎性浸润,并有红细胞外渗。未发现白细胞破碎性血管炎的改变。利奈唑胺随即停用。据我们所知,这是首例经活检证实的利奈唑胺治疗继发的紫癜性药物反应报告。